NFlection Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2014-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.nflectionrx.com
Atai Life Sciences Bolsters Leadership Team to Advance Psychedelic Therapeutics Pipeline
• Atai Life Sciences appoints Srinivas Rao as sole CEO, promoting Kevin Craig to CMO and Glenn Short to CSO.
• Gerd Kochendoerfer joins as COO to enhance strategic alignment and operational excellence for clinical programs.
• The leadership changes support the advancement of VLS-01 and EMP-01 into Phase 2 trials for mental health disorders.
• Atai anticipates Phase 2b data readout for Beckley Psytech's BPL-003, a key step for scalable psychedelic therapies.
© Copyright 2025. All Rights Reserved by MedPath